Tracking tiny patients: major study launches to monitor blood thinner safety in infants
NCT ID NCT05900388
Summary
This study aims to collect real-world information on how doctors prescribe and use blood-thinning medications (like rivaroxaban) to treat dangerous blood clots in babies and toddlers under 2 years old. Researchers will review the medical records of about 850 children who are already receiving this standard care to understand treatment patterns and monitor for serious bleeding events. The goal is to gather safety and usage data to better inform future care for this very young, vulnerable patient group.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENOUS THROMBOEMBOLISM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Many locations
Multiple Locations, Denmark
-
Many locations
Multiple Locations, France
-
Many locations
Multiple Locations, Spain
-
Many locations
Multiple Locations, Sweden
Conditions
Explore the condition pages connected to this study.